Comparing Mainstream and Enhanced Standard Care Models for Cancer Genetic Testing in Federally Qualified Health Centers
Led by University of Illinois at Chicago · Updated on 2026-01-14
80
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating two different models of cancer genetic service delivery to improve access for patients at risk for hereditary breast or colon cancer syndromes in urban Federally Qualified Health Centers FQHCs. This study compares a mainstream genetic testing model MGT, where primary care providers directly offer genetic testing, with an enhanced standard of care model SOC that includes patient navigation support alongside referrals to genetic counseling. The goal is to identify which approach leads to higher uptake of genetic testing and to understand barriers and facilitators in these community health settings.
The study involves four community health clinics within an FQHC network, each assigned to use either the MGT or SOC model. In the MGT model, primary care providers educate, counsel, and order genetic tests directly, referring patients to genetics specialists only if abnormal results occur. The SOC model enhances the usual referral process by adding universal electronic hereditary cancer risk assessment and patient navigation to address barriers like financial concerns. Data such as patient demographics, referrals, testing completion, and timing will be collected, and interviews with patients, providers, and staff will explore their experiences with each model.
Participants will be adults aged 25 and older who are English-speaking and eligible for genetic testing based on established criteria. The study will collect information from medical records over two years to measure uptake and timing of genetic testing. Qualitative interviews will assess acceptability, feasibility, and sustainability of each service model. This research aims to provide evidence for scalable, equitable genetic services in underserved primary care settings, with participant involvement lasting up to two years.
CONDITIONS
Brief Title
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
Research Team
P
Pamela Ganschow, MD
A
Angelina Izguerra
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Mainstream Genetic Testing (MGT) Model
Enhanced Standard of Care (SOC) Model
What it is
Cancer genetic testing is delivered directly by primary care providers in the federally qualified health center, making testing more accessible within routine care.
Participants are referred to external specialty genetics services for counseling and testing, with additional processes to enhance access compared to usual care.
Role in study
Intervention arm being evaluated for improving access, uptake, and implementation of cancer genetic testing in primary care clinics.
Comparator arm providing an enhanced version of the standard pathway for cancer genetics referral and testing.
Primary use
Identifying adults at risk for hereditary breast or colorectal cancer syndromes and providing genetic testing and results as part of their routine primary care.
Identifying adults at risk for hereditary breast or colorectal cancer syndromes, referring them for specialty genetics counseling and testing, and supporting enhanced referral processes.
How it is given or performed
Primary care providers coordinate pre-test counseling, order genetic testing, and share results with patients within the primary care visit.
Patients are identified as eligible, then referred out to specialty genetics services for counseling and testing by genetics professionals.
Evidence status
Effectiveness in increasing genetic testing uptake is under investigation; external studies support that primary care coordination can improve access to genetic services in underserved populations.
Uptake and timely delivery of genetic testing using enhanced referral processes are measured; effectiveness depends on successful patient referral and completion of genetics services.
Important limitations
Primary care-based testing may face logistical challenges, including provider time constraints, limited genetics expertise among primary care staff, and possible need for additional support to ensure test result follow-up.
Enhanced referrals may not reach all eligible patients due to system limitations, possible patient non-completion of referral, and barriers in coordination between primary care and genetics specialty services.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 25Years +
All Genders
Eligibility Criteria
You may qualify if you...
Adults age 25 and older
English speaking
Eligible for cancer genetic testing for hereditary breast or colon cancer syndromes as defined by NCCN criteria
Screened positive and agreed to be contacted for virtual or telephone interviews about cancer genetics services
Receiving care from one of the four participating Federally Qualified Health Center clinics
You will not qualify if you...
Did not meet the inclusion criteria
Did not screen positive on hereditary cancer risk assessment or did not agree to be contacted for interviews
Not a patient receiving care from one of the enrolled clinics in the clinical trial
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person or virtual)
Implementation
Duration - Up to 2 years
Participants receive cancer genetic services through one of two models: the mainstream genetic testing model where genetic testing is integrated into primary care visits; or the enhanced standard of care model which includes referral to genetic counseling with additional support for health literacy.
Visits occur during primary care appointments as part of routine healthcare; additional contacts may occur depending on the model assigned
Follow-up
Duration - Up to 2 years
Participants are observed to evaluate uptake of genetic testing, time to testing, and implementation outcomes including acceptability, feasibility, and sustainability of the genetic service delivery approaches.
Data collected through electronic medical records; some participants may have interviews via phone or virtual visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Evaluating Cell-free DNA Blood Testing for Early Cancer Detection in Hereditary and High-risk Cancer Syndromes
Study of a Chatbot to Improve Genetic Risk Assessment for Hereditary Cancer in Gynecology Patients
Using Electronic Health Record Tools and Decision Support to Enhance Genetic Testing for Hereditary Breast and Ovarian Cancer in Women
Evaluating Combined Obstetrical Carrier and Hereditary Cancer Screening During Prenatal Care at Columbia University
Comparing Mainstream and Enhanced Standard Care Models for Cancer Genetic Testing in Federally Qualified Health Centers
Study of TP53 Gene Variants and Li-Fraumeni Syndrome to Understand Cancer Risks and Improve Prevention
Study of Immune System Role in Colorectal Cancer Development in Adults with Lynch Syndrome
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
TestMiGenes: A hybrid effectiveness-implementation mixed methods study evaluating cancer genetic service delivery models in primary care at a federally qualified health center.